← Product Code [LLZ](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ) · K022896 # CSV12 SOFTWARE VIEWER (K022896) _Acuson Corp. · LLZ · Oct 3, 2002 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ/K022896 ## Device Facts - **Applicant:** Acuson Corp. - **Product Code:** [LLZ](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ.md) - **Decision Date:** Oct 3, 2002 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 892.2050 - **Device Class:** Class 2 - **Review Panel:** Radiology - **Attributes:** Software as a Medical Device ## Intended Use The intended use of the CSV12 Software Viewer is acceptance, transfer, display, storage, and digital processing of Cypress diagnostic ultrasound images and image manipulation and quantification. No new intended uses are claimed for the modifications. ## Device Story CSV12 Software Viewer is a software-only application for PCs designed for off-line management of ultrasound studies. It functions as an accessory to the Acuson Cypress Diagnostic Ultrasound System. The software ingests full-resolution R-Theta file formats from Cypress ultrasound studies; it enables clinicians to view, store, and perform quantification on these images independently of the ultrasound system. It supports data transfer via DICOM or native Cypress formats, magneto-optical drives, or network connections. By duplicating the patient database and viewing capabilities of the original ultrasound system, it allows clinicians to review studies off-line, facilitating clinical decision-making by providing access to original-quality images outside the immediate scanning environment. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Software-only application for PC. Supports DICOM and native Cypress file formats. Enables image display, storage, and quantification. Connectivity via network or magneto-optical drive. No hardware components. ## Regulatory Identification A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements. ## Special Controls *Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern). ## Predicate Devices - Acuson Cypress System ([K021497](/device/K021497.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ### Section 9 # OCT 0 3 2002 ### 510(k) Summary of Safety and Effectiveness ### Acuson Corporation's Cypress CSV12 Software Viewer Acuson Corporation has not disclosed its intent to market this device modification and requests this notification be held CONFIDENTIAL by FDA, and not be released to any Freedom of Information request or addressed with any outside parties. | Sponsor: | Acuson Corporation
1220 Charleston Road | |------------------|--------------------------------------------------------------------------------------------------------| | | Mountain View, CA 94039-7303 | | Contact Person: | Bob Leiker
Senior Regulatory Affairs Specialist
Telephone: (650) 694-5080
Fax: (650) 961-6168 | | Submission Date: | August 30, 2002 | | Device Name: | CSV12 Software Viewer, an accessory for the Acuson Cypress Ultrasound
System | Common or Usual Name: Picture Archival and Communications System #### Classification: Picture Archival and Communications System (LLZ) class II (21CFR §892.2050) #### Predicate Device: K021497, July 09, 2002, cleared as the Acuson Cypress System #### Device Description: This modification is a software-only version of the Acuson Cypress Diagnostic Ultrasound System Image Viewer and is described as the CSV12 Software Viewer. The modifications implemented in the CSV12 Viewer Software are to provide off-line image management of ultrasound studies and images on a PC and may be operated independently as a software-only product. The CSV12 Software Viewer, when running on a personal computer (PC) duplicates the patient database, study storage, viewing, and quantification capability of the Cypress ultrasound system. This provides clinicians with a simple means of viewing studies off-line. Because it can read the full-resolution R-Theta file formats of the Cypress diagnostic ultrasound images, the CSV12 Software Viewer displays images in real-time without any compression, duplicating the original quality of the images on the Cypress diagnostic ultrasound system. {1}------------------------------------------------ #### Intended Use: The intended use of the CSV12 Software Viewer is acceptance, transfer, display, storage, and digital processing of Cypress diagnostic ultrasound images and image manipulation and quantification. No new intended uses are claimed for the modifications. #### Technological Characteristics and Substantial Equivalence: The modified CSV12 Software Viewer is substantially equivalent to the predicate device, Cypress Diagnostic Ultrasound System Image Viewer, with respect to intended use and indications for use, principles of operation, and technological characteristics and design. It is comparable in key safety and effectiveness features. Studies may be transmitted in DICOM or native Cypress format, to an integrated magneto-optical drive, or over a network. {2}------------------------------------------------ #### DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around it. Inside the circle is a stylized image of an eagle with three lines representing its body and wings. #### Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ### OCT 0 3 2002 Mr. Bob Leiker Senior Regulatory Affairs Specialist Acuson Corporation 1220 Charleston Road MOUNTAIN VIEW CA 94039 Re: K022896 Trade/Device Name: CSV12 Software Viewer Regulation Number: 21 CFR §892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: 90 LLZ Dated: August 30, 2002 Received: September 3, 2002 Dear Mr. Leiker: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 8xx.1xxx | (301) 594-4591 | |----------------------------------|----------------| | 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 | | 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 | | 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 | | Other | (301) 594-4692 | Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html. Sincerely yours, Nancy C Brogdon Nancy C. Brogdon Director, Division of Reproductive. Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Section 10 ## Indications For Use The intended use of the CSV12 Software Viewer is for the acceptance, transfer, display, storage, and digital processing of Cypress Diagnostic Ultrasound System images, including image manipulation and quantification. Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) Daniel A. Seymour (Division Sign-Off) Division of Reproductio and Radiological Devic 510(k) Number --- **Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ/K022896](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ/K022896) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com